mRNA, Spike Protein & Exosomes
What is really going on in our bodies?
We were told the mRNA from cv19 vaccines breaks down quickly, and for most people, that seems to be true, in that they are feeling healthy and well.
But what about those reporting lingering symptoms, immune shifts, or unusual fatigue, emotional changes, mental wellness challenges months and years now, after the jab?
Could the spike protein be hanging around longer than expected?
And if so, why?
Could exosomes, tiny cellular messengers, be playing a role in how spike protein is shared or signalled throughout the body? These aren’t just fringe questions.
They point to a deeper need to understand how the body processes novel vaccine technologies, and why not all responses are the same.
This article only provides some small insight.
What Is mRNA and What Does It Do in the Vaccine?
Messenger RNA (mRNA) is a single-stranded molecule that carries genetic instructions from DNA to the ribosomes, where proteins are made. In the context of the CV19 vaccine, synthetic mRNA is used to temporarily instruct your cells to produce the SARS-CoV-2 spike protein.
The mRNA never enters the cell’s nucleus, so it does not alter your DNA. At least that is what we have been told. Instead, the mRNA stays in the cytoplasm where it’s read by ribosomes, much like a temporary recipe. Once the protein is made, the mRNA breaks down rapidly, usually within hours to a few days. This was the premise.
The Spike Protein - What It Is and Why It Matters
The spike protein is a structural protein found on the surface of coronaviruses.
It's called "spike" because it appears as protrusions or spikes on the virus’s outer shell. The protein binds to a receptor on human cells called ACE2, which acts like a doorway for the virus to enter.
mRNA vaccines teach the body to make this spike protein (without the virus itself) so the immune system can recognise and destroy the ‘virus’ if you’re ever exposed to the actual virus. In the lab it appeared to be an effective training tool, but the presence of spike protein alone may trigger immune responses, even after the mRNA is gone. The idea that human’s can and are playing around with the bodies natural processes is scary, but a current day reality.
Why mRNA Breaks Down Quickly (But Spike Protein Might Not)
Synthetic mRNA is designed to degrade rapidly, as it’s made from the same unstable materials as natural mRNA. However, once the spike protein is produced, it may persist for longer, particularly if it is not quickly tagged and cleared by the immune system.
Studies have found spike protein fragments in blood or tissue weeks, months, years after vaccination in some people. This doesn’t necessarily mean the body is still making it, but rather that it hasn’t fully cleared it. In most people, immune clearance works efficiently. In others, it may be slower or incomplete.
So Why Is Spike Protein Still Detected in Some People?
There are a few emerging theories:
Slow clearance: In some individuals, especially those with existing immune dysfunction, the body may take longer to break down and remove the spike protein.
Tissue uptake: Some immune or endothelial cells may hold onto spike protein longer than expected.
Exosome-mediated persistence: The spike protein (or its fragments) may be packaged into exosomes and distributed to other tissues, prolonging immune activation.
These aren’t signs of ongoing mRNA activity, but they do raise questions about how the body handles vaccine-generated proteins over time.
Exosomes: The Body’s Tiny Couriers
Exosomes are small, bubble-like vesicles released by nearly all cell types. They carry proteins, lipids, and genetic material between cells. Think of them as microscopic mail carriers that deliver molecular messages.
After mRNA vaccination, cells that produce spike protein may release exosomes containing parts of the spike protein. This could help alert the immune system,
but may also allow the protein to reach parts of the body far from the injection site.
In some cases, exosomes might prolong the presence of spike protein in circulation or tissues.
Exosomes are not inherently bad; they’re part of normal cell communication. But when they carry pro-inflammatory or poorly cleared proteins, they may play a role in long-term symptoms.
Lipid nanoparticles (LNPs)
LNPs are tiny fat-based carriers used to deliver genetic material, like mRNA, in vaccines such as Pfizer and Moderna’s cv19 shots.
Here's what you need to know about them:
Purpose: LNPs protect the fragile mRNA and help it enter human cells, where the mRNA instructs the cell to produce the spike protein (which then triggers an immune response).
Structure: Think of them like microscopic bubbles made of synthetic fats (lipids), often PEGylated (coated with polyethylene glycol) to increase stability.
Persistence: Some studies suggest LNPs can travel beyond the injection site, entering the bloodstream and reaching various tissues, including reproductive organs, liver, spleen, and brain.
Concerns: While meant to degrade, there’s ongoing debate about how long they persist in the body and whether they contribute to inflammation, immune activation, or cellular stress, particularly if detoxification pathways (liver, lymph, gut) are sluggish.
In a detox context, LNPs are considered part of the “toxic load” that the body may still be clearing months or even years later, especially in those with fatigue, cycle changes, or systemic inflammation.
Individual Variation - Why Every Body Responds Differently
Surprisingly, or not so surprisingly, not everyone processes vaccines, or viral proteins, the same way. Factors that influence variation include:
Genetic differences in immune pathways
Hormonal status (e.g., postmenopausal women may respond differently)
Chronic inflammation or autoimmune conditions
Previous exposure to the virus
Dietary and lifestyle factors
Some individuals experience a natural immune response and clear the spike protein efficiently.
Others suffer ongoing or long-term effects, sometimes amounting to chronic injury.
In many cases, a slower or dysregulated immune response contributes to prolonged symptoms.
A growing number of people report changes in brain function, emotional regulation, and mental well-being, signs that suggest neurological involvement and disruption across the blood-brain barrier.
What We Know, What We Don’t, and Why It Matters
What we have been told:
This synthetic mRNA was not designed to enter the nucleus or alter DNA.
The body makes spike protein briefly, then breaks down the mRNA.
Most people clear the spike protein.
What’s still being studied:
Why some people show evidence of spike protein month, years later?
The role of exosomes in protein persistence and symptom distribution.
How to support the body in clearing spike protein more effectively.
What we don’t know:
How the mRNA injections respond to each individual body, with its inherent individual responses and immune system
Exosome ongoing transportation and messaging
The role of LNPs in spike protein persistence, other symptoms and symptom distribution
Persistence of spike protein production
The full ingredients of the vaccines
Understanding these processes is not to create fear, it’s about informed health.
For those with persistent symptoms, having a scientific explanation opens the door to appropriate support and care.